D. Jacob et al., EFFECTS OF CALCIUM-ANTAGONISTS ON BINDING OF LOCAL-ANESTHETICS TO PLASMA-PROTEINS AND ERYTHROCYTES IN MICE, Pharmacology, 53(4), 1996, pp. 219-223
This study was designed to document possible changes in the binding of
bupivacaine (BV), lidocaine (LC) and their main metabolites desbutylb
upivacaine (PPX) and monoethylglycinexylydide (MEGX), respectively, to
plasma proteins and erythrocytes in mice after acute treatment with t
he calcium antagonists diltiazem (DZ), nicardipine (NP) and verapamil
(VP). A significant plasma protein binding of BV, LC and PPX was measu
red, whereas no binding could be detected for MEGX. The binding of BV
was not modified by DZ, NP and VP, however, the total plasma level was
increased in the presence of VP. For PPX a significant increase in to
tal and free plasma levels and a decrease in protein binding were demo
nstrated after DZ and VP treatment. Concerning LC, a significant incre
ase in total and free plasma levels was documented for DZ, NP and VP s
uggesting an inhibition of the metabolism of LC by the calcium antagon
ists. An increased penetration of LC into erythrocytes was also demons
trated which is consistent with the calcium antagonist-induced increas
e in LC free plasma levels. These effects may contribute in part to th
e previously observed increase in toxicity of BV by calcium antagonist
s, but are not likely to be the sole mechanism.